Tweets by FSCDR's 17th Annual SCD Research and Educational Symposium & 46th Nat'l SCD Scientific Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Stream

NOTE: All events are in Eastern Daylight Time Zone. Please visit your Symposium Profile to verify your time zone. We recommend displaying all times in the event time zone.

“Is Wall Street Still Interested in Sickle Cell Disease?” Panel

Friday, June 16, 2023

5:30 PM – 6:30 PM East Coast USA Time

Location: Grand Salons A-E

Chair(s)

Ted W. Love, MD (he/him/his)

Former CEO
Global Blood Therapeutics
San Francisco, California, United States

Panelist(s)

Gerard Smith, MD

Principal
Deep Track Capital
Greenwich, Connecticut, United States
Jim Birchenough, MD (he/him/his)

Vice Chairman
Wells Fargo Biopharmaceutical Investment Banking
Tiburon , California, United States

Disclosure(s):

Ted W. Love, MD: No financial relationships to disclose

Gerard Smith, MD: No financial relationships to disclose

Jim Birchenough, MD: No financial relationships to disclose

Learning Objectives:

What would inspire a company or investors to be interested in investing in Sickle Cell Disease?
Can the Sickle Cell community impact these investments, if so how?
What factors will discourage Wall Street investment in SCD?